These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 11952281

  • 1. Suspected cutaneous anthrax in a laboratory worker--Texas, 2002.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2002 Apr 05; 51(13):279-81. PubMed ID: 11952281
    [Abstract] [Full Text] [Related]

  • 2. Update: Cutaneous anthrax in a laboratory worker--Texas, 2002.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2002 Jun 07; 51(22):482. PubMed ID: 12064454
    [Abstract] [Full Text] [Related]

  • 3. From the Centers for Disease Control and Prevention. Suspected cutaneous anthrax in a laboratory worker--Texas, 2002.
    JAMA; 2002 May 08; 287(18):2356-8. PubMed ID: 12001943
    [No Abstract] [Full Text] [Related]

  • 4. From the Centers for Disease Control and Prevention. Public health dispatch: update: cutaneous anthrax in a laboratory worker-Texas, 2002.
    JAMA; 2002 May 08; 288(4):444. PubMed ID: 12141318
    [No Abstract] [Full Text] [Related]

  • 5. Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2001 Nov 30; 50(47):1049-51. PubMed ID: 11808925
    [Abstract] [Full Text] [Related]

  • 6. Bacillus anthracis contamination and inhalational anthrax in a mail processing and distribution center.
    Sanderson WT, Stoddard RR, Echt AS, Piacitelli CA, Kim D, Horan J, Davies MM, McCleery RE, Muller P, Schnorr TM, Ward EM, Hales TR.
    J Appl Microbiol; 2004 Nov 30; 96(5):1048-56. PubMed ID: 15078521
    [Abstract] [Full Text] [Related]

  • 7. Cross-contamination of clinical specimens with Bacillus anthracis during a laboratory proficiency test--Idaho, 2006.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 Sep 12; 57(36):993-5. PubMed ID: 18784641
    [Abstract] [Full Text] [Related]

  • 8. Factors influencing laboratory workers' decisions to accept or decline anthrax vaccine adsorbed (AVA): results of a decision-making study in CDC's anthrax vaccination program.
    Fowler GL, Baggs JM, Weintraub ES, Martin SW, McNeil MM, Gust DA.
    Pharmacoepidemiol Drug Saf; 2006 Dec 12; 15(12):880-8. PubMed ID: 16924600
    [Abstract] [Full Text] [Related]

  • 9. Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2001 Nov 09; 50(44):973-6. PubMed ID: 11724150
    [Abstract] [Full Text] [Related]

  • 10. Update: Investigation of bioterrorism-related anthrax, 2001.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2001 Nov 16; 50(45):1008-10. PubMed ID: 11724158
    [Abstract] [Full Text] [Related]

  • 11. Update: Investigation of bioterrorism-related anthrax--Connecticut, 2001.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2001 Dec 07; 50(48):1077-9. PubMed ID: 11770501
    [Abstract] [Full Text] [Related]

  • 12. Suspected outbreak of cutaneous anthrax in Kasese district, the investigation and response, April to May 2007.
    Bazeyo W, Lukwago L, Wamala J, Obayo S, Bua J, Ecumu J, Baluku P, Mukobi P.
    East Afr J Public Health; 2009 Dec 07; 6(3):235-9. PubMed ID: 20803911
    [Abstract] [Full Text] [Related]

  • 13. Interim guidelines for investigation of and response to Bacillus anthracis exposures.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2001 Nov 09; 50(44):987-90. PubMed ID: 11724154
    [Abstract] [Full Text] [Related]

  • 14. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2001 Nov 02; 50(43):941-8. PubMed ID: 11708591
    [Abstract] [Full Text] [Related]

  • 15. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2001 Oct 19; 50(41):889-93. PubMed ID: 11686472
    [Abstract] [Full Text] [Related]

  • 16. Occupational health guidelines for remediation workers at Bacillus anthracis-contaminated sites--United States, 2001-2002.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2002 Sep 06; 51(35):786-9. PubMed ID: 12227440
    [Abstract] [Full Text] [Related]

  • 17. Inadvertent laboratory exposure to Bacillus anthracis--California, 2004.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2005 Apr 01; 54(12):301-4. PubMed ID: 15800474
    [Abstract] [Full Text] [Related]

  • 18. Responding to a bioterrorist attack: environmental investigation of anthrax in New Jersey.
    Valiante DJ, Schill DP, Bresnitz EA, Burr GA, Mead KR.
    Appl Occup Environ Hyg; 2003 Oct 01; 18(10):780-5. PubMed ID: 12959889
    [Abstract] [Full Text] [Related]

  • 19. Considerations for distinguishing influenza-like illness from inhalational anthrax.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2001 Nov 09; 50(44):984-6. PubMed ID: 11724153
    [Abstract] [Full Text] [Related]

  • 20. Cutaneous anthrax associated with drum making using goat hides from West Africa--Connecticut, 2007.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 Jun 13; 57(23):628-31. PubMed ID: 18551098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.